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DNA fragmentation is the hallmark of apoptotic cells and mainly mediated by the DNA fragmenta-
tion factor DFF40(CAD)/DFF45(ICAD). DFF40 is a novel nuclease, whereas DFF45 is an inhibitor that
can suppress the nuclease activity. Apoptotic DNA fragmentation in the ﬂy is controlled by four DFF-
related proteins, known as Drep1, 2, 3 and 4. However, the functions of Drep2 and Drep3 are totally
unknown. Here, we found that Drep2 is a novel nuclease whose activity is inhibited by Drep3
through a tight interaction with the CIDE domain. Our results suggest that the ﬂy has dual apoptotic
DNA fragmentation systems: Drep1:Drep4 and Drep2:Drep3 complexes.
Structured summary of protein interactions:
Drep2 CIDE and Drep-3 CIDE bind by blue native page (View interaction)
Drep2 CIDE and Drep-3 CIDE bind by molecular sieving (View interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Apoptosis is anorderly cellular suicideprocess in response to var-
ious stimuli [1,2] and failure to control apoptosis can cause serious
human diseases such as cancer, autoimmune disorders, and Alzhei-
mer’s disease [3–6]. Characteristic changes in chromosomes, such as
chromatin condensation and cleavage, are hallmarks of apoptosis
and are often used as a tool to detect apoptotic cell death [7–9].
Previous studies have revealed that apoptotic DNA fragmentation
is mediated by a novel DNA fragmentation factor (DFF), which is
composed of a heterodimeric complex called DFF40 (CAD: mouse
homologue):DFF45 (ICAD: mouse homologue). The DFF40:DFF45
complex was ﬁrst identiﬁed as dependent on caspase-3 activity in
the human Hela S-100 fraction [8]. DFF40 is a novel nuclease with
a nuclear localization signal, whereas DFF45 is an inhibitor that
suppresses DFF40 nuclease activity via tight interaction. Interest-
ingly, DFF45 seems to function as a chaperone for DFF40 during its
synthesis [7,10,11]. When effector caspases such as caspase-3 are
activated by apoptotic stimuli, they cleave DFF45, allowing DFF40
to enter the nucleus and degrade chromosomal DNA [9,12]. During
this process, DNA undergoes fragmentation and is eventually
cleaved into regular 180 bp fragments [8,9].chemical Societies. Published by EApoptosis and apoptotic DNA fragmentation is conserved among
different species including Drosophila melanogaster, and several
homologous proteins of the DFF40:DFF45 complex have been iden-
tiﬁed [13]. Unlike the mammalian system, apoptotic DNA fragmen-
tation in the ﬂy is controlled by four DFF-related proteins known as
Drep1 (dDFF45), Drep2, Drep3, and Drep4 (dDFF40) [13]. Drep1 and
Drep4 are DFF45 and DFF40 homologues, respectively [14].
Although no clear evidence has been presented, Drep2 and Drep3
are regulators of the DFF system during apoptosis in the ﬂy [13].
All four proteins have a conserved CIDE domain, which is involved
in protein–protein interactions [15]. The CIDE domain-containing
proteins, called CIDE family proteins, have been detected in many
mammalian systems as well as the ﬂy [16], but the function of these
proteins, including Drep2 and Drep3 are not clear.
To elucidate the possible function of Drep2 and Drep3 and
understand the mechanism of apoptotic DNA fragmentation in
the ﬂy system, we puriﬁed Drep2, Drep3, and their CIDE domains
and performed a biochemical study. As a result, we found that
full-length Drep2 exists as a highly oligomeric form mediated by
CIDE domain oligomerization in solution unlike Drep3, which usu-
ally exists as a monomer in solution. We also found that Drep2 has
nuclease activity, and that Drep2 nuclease activity was inhibited by
Drep3 by a direct interaction. Based on our results, we conclude
that the ﬂy has a dual apoptotic DNA fragmentation system: a
Drep1:Drep4 complex and a Drep2:Drep3 complex. Drep4 andlsevier B.V. All rights reserved.
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2. Materials and methods
2.1. Protein expression and puriﬁcation
Full-length Drep1 (amino acid residues: 1–297), Drep2 (amino
acid residues: 1–481) and Drep3 (amino acid residues: 1–242) were
ampliﬁed by polymerase chain reaction (PCR) using gene-speciﬁc
primers containing the NdeI and XhoI sites. The PCR fragmentswere
subsequently digested and ligated into the pOKD5 home-made vec-
tor for Drep1 and Drep3 and the pET26b vector for Drep2. PCR frag-
ments for the CIDE domains of Drep1 corresponding to amino acids
1–90, Drep2 corresponding to amino acids 1–84, and Drep3 corre-
sponding to amino acids 112–195 were similarly prepared and
cloned into the pOKD vector for Drep3 CIDE, the pER28a vector for
Drep1 CIDE, and the pET26b vector for Drep2 CIDE.
All recombinant proteins were expressed in Escherichia coli
BL21 (DE3) and puriﬁed by quick two-step chromatography.
Expression was induced by treating the bacteria with 0.5 mM iso-
propyl b-D-thiogalactopyranoside (IPTG) overnight at 293 K. The
bacteria were then collected, resuspended, and lysed by sonication
in 50 ml lysis buffer (20 mM Tris–HCl pH 7.9, 500 mM NaCl, and
10 mM imidazole). The bacterial lysate was then centrifuged at
16,000 rpm for 1 h at 4 C. The supernatant fraction was applied
to a gravity-ﬂow column (Bio–Rad, Hercules, CA, USA) packed with
Ni-NTA afﬁnity resin (Qiagen, Valencia, CA, USA). The unbound
bacterial proteins were removed from the column with a washingFig. 1. Puriﬁcation of full-length Drep2 and Drep3 and their CIDE domains. (A) Domain
number of amino acid corresponding to the CIDE domain is indicated. (B) Gel-ﬁltratio
obtained from the full-length Drep2 in 150 mM NaCl and Tris buffer pH 8.0 is shown as a
buffer pH 8.0 is shown as a black line. SDS–PAGE stained by Coomassie Blue from the pe
ﬁltration chromatograms and fractions of full-length Drep3 and its CIDE domain. Proﬁle o
as a black dot. Proﬁle obtained from the Drep3 CIDE domain in 150 mM NaCl and Tris bu
peak fraction of gel-ﬁltration chromatography is shown next to each peak.buffer (20 mM Tris–HCl pH 7.9, 500 mM NaCl, 60 mM imidazole,
and 10% glycerol). The target proteins were eluted from the column
using an elution buffer (20 mM Tris–HCl pH 7.9, 500 mM NaCl, and
250 mM imidazole). Protein purity was further improved using a
Superdex 200 gel ﬁltration column (Pharmacia, Piscataway, NJ,
USA) pre-equilibrated with a buffer containing 20 mM Tris–HCl
pH 8.0 and 150 mM NaCl.
2.2. Complex assay using gel-ﬁltration chromatography
Puriﬁed Drep2 CIDE was mixed with a molar excess of Drep3
CIDE and applied to a gel-ﬁltration column (Superdex 200 HR 10/
30, GE Healthcare), which was pre-equilibrated with 20 mM
Tris–HCl, pH 8.0, and 150 mM NaCl. The fractions were collected
and subjected to SDS–PAGE.
2.3. Native PAGE shift assay
The protein interaction between Drep2 CIDE and Drep3 CIDE
was monitored by native (non-denaturing) PAGE on a PhastSystem
(GE Healthcare) with pre-made 8–25% acrylamide gradient gels
(GE Healthcare). Separately puriﬁed proteins were pre-incubated
at room temperature for 1 h before loading the gel. Coomassie
Brilliant Blue was used for staining and detecting shifted bands.
2.4. Pull-down assay
A co-expression system was used to perform the pull-down
assay. Drep2 CIDE in pET26b and Drep2 CIDE with no-tag in theboundaries of Drep1, 2, and 3. Each CIDE domain is colored in gray and the residue
n chromatograms and fractions of full-length Drep2 and its CIDE domain. Proﬁle
black dot. Proﬁle obtained from the CIDE domain of Drep2 in 150 mM NaCl and Tris
ak gel-ﬁltration chromatography fraction is shown at the upper right side. (C) Gel-
btained from the full-length Drep2 in 150 mM NaCl and Tris buffer pH 8.0 is shown
ffer pH 8.0 is shown as a black line. SDS–PAGE stained by Coomassie Blue from the
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competent cells. The expression was induced with 0.5 mM IPTG
overnight at 20 C. The cells were collected and lysed by sonication
in lysis buffer (20 mM Tris buffer at pH 7.9, 500 mM NaCl, and
10 mM imidazole). The lysate was then removed by centrifugation,
and the supernatant fractions were applied to gravity-ﬂow column
(Bio-rad) packed with Ni-NTA afﬁnity beads (Qiagen). The unbound
bacterial proteins were removed from the column with a washing
buffer (20 mM Tris–HCl at pH 7.9, 500 mM NaCl, 60 mM imidazole,
and 10% glycerol). The stable complex was detected by SDS–PAGE.
2.5. Nuclease activity assay
Puriﬁed Drep1, 2, and 3 (10 lg) were preincubated with 4 lg of
linearized plasmid DNA at 37 C for 1 h in a ﬁnal volume of 20 ll in
a buffer containing 20 mM Hepes pH 7.4, 5 mMMgCl2 50 mM NaCl,
and 5 mM EGTA. The reaction was run on a 2% agarose gel for
30 min at 150 V. Puriﬁed Drep1 or Drep3 was mixed with Drep2 at
20 C for 30 min before adding plasmid DNA for the inhibition assay.
3. Results and discussion
3.1. Puriﬁcation and characterization of full-length Drep2 and Drep3
and their CIDE domains
DNA fragmentation is the hallmark of apoptotic cell death and is
mainly performed by the DNA fragmentation factor DFF40:DFF45
complex. Four DFF-like proteins occur in the ﬂy: Drep1, Drep2,Fig. 2. Drep2 interacts with Drep3 via the CIDE domain. (A) Gel ﬁltration chromatogram a
Drep3 CIDE mixture, Gray dot: Drep3 CIDE, Gray line: Drep2 CIDE. SDS–PAGE of the peak
CIDE is shown at right side. The complex fraction is indicated by the dotted-box. (B) Na
RAIDD DD only (negative control); lane 2, Drep2 CIDE only; lane 3, Drep3 CIDE only; lane
6, Drep2 CIDE mixed with Drep3 CIDE. The complex band is indicated by arrow. (C) Co-exp
1, markers; lane 2, supernatant of the cell lysate; lane 3, ﬂow through after incubation w
250 mM imidazole eluted fractions.Drep3, and Drep4. All three proteins, which were used in our study,
have a well conserved CIDE domain that is involved in protein–pro-
tein interactions (Fig. 1A). AlthoughDrep1 andDrep4 are DFF45 and
DFF40 homologues, respectively, the function of Drep2 andDrep3 is
still unclear. As a ﬁrst step to elucidate the function of Drep2 and
Drep3, we expressed and puriﬁed each CIDE domain of Drep 2 and
Drep3 as well as the full-length proteins. Drep4 was not expressed
in E. coli,whereas Drep1, Drep2, Drep3, and each CIDE domain were
expressed well in E. coli as C-terminal His-tag fusion proteins and
puriﬁed by Ni afﬁnity chromatography followed by gel-ﬁltration
chromatography at 4 C (Fig. 1B and C). Interestingly, full-length
Drep2 and Drep2 CIDE seemed to be in a highly oligomeric state in
solution unlike Drep3 CIDE, judging by the gel-ﬁltration chromatog-
raphy (Fig. 1B and C). Drep2 and Drep2 CIDE eluted in 10 ml on a
Superdex 200 gel-ﬁltration column, which corresponded to a size
of >150 kDa (Fig. 1B). Drep3 andDrep3CIDE eluted at approximately
15 and 16 ml respectively (Fig. 1C). Based on this preliminary result,
we concluded that Drep2 exists as a highly oligomeric form medi-
ated by CIDE domain oligomerization in solution, unlike Drep3,
which usually exists as a monomer in solution. This result also
indicates that the CIDE domain, which is a protein interactionmod-
ule involved in hetero-dimerization, can be self-oligomerized.
3.2. Drep2 interacts with Drep3 via the CIDE domain
Puriﬁed recombinant Drep2 and Drep3 proteins and their CIDE
domains were used for an analysis of their interactions. To analyze
the interaction of Drep2 with Drep3, puriﬁed Drep2 CIDE wasnd fractions of a mixture of Drep2 CIDE and Drep3 CIDE. Black line: Drep2 CIDE and
gel-ﬁltration chromatography fractions from the mixture of Drep2 CIDE and Drep3
tive-PAGE analysis of the interaction between Drep2 CIDE and Drep3 CIDE: Lane 1,
4, Drep3 CIDE mixed with RAIDD DD; lane 5, Drep2 CIDE mixed with RAIDD DD; lane
ression and His-tag pull-down of Drep3 CIDE-noHis by His-tagged Drep2 CIDE. Lane
ith Ni-NTA beads; lane 4, washing buffer containing 20 mM imidazole; lanes 5–9,
Fig. 3. Drep2 is a nuclease that is inhibited by Drep3. (A) Nuclease activity assay shows degradation of linearlized plasmid DNA. Lane 1, DNAmarkers; lane 2, DNA with water
(negative control); lane 3, DNA with puriﬁed Drep1; lane 4, DNA with puriﬁed Drep2; lane 5, DNA with puriﬁed Drep3. (B) Nuclease inhibitory assay shows blocking
degradation of linearlized plasmid DNA. Lane 1, DNA markers; lane 2, DNA with water (negative control); lane 3, DNA with Drep2; lane 4, DNA with the Drep2 and
Drep1protein mixture; lane 4, DNA with a mixture of Drep2 and Drep3.
Fig. 4. Drep3 is cleaved by caspase-1 (Dcp1) and may be involved in apoptotic DNA
fragmentation. (A) Predicted caspase-1 cleavage site on Drep3. Possible cleavage
sites are indicated by the red line. The prediction was made by CASVM server 1.0
(http://www.casbase.org/casvm/server/index.html). (B) Model for the dual apop-
totic DNA fragmentation system in the ﬂy.
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room temperature and then applied to a S-200 gel-ﬁltration col-
umn. The Drep2 CIDE:Drep3 CIDE complex was obtained, as shown
by gel ﬁltration chromatography and SDS–PAGE (Fig. 2A). An obvi-
ously shifted peak and co-migration on SDS–PAGE indicated that
Drep2 CIDE interacts tightly with Drep3 CIDE (Fig. 2A). These inter-
actions were also conﬁrmed by native-PAGE (Fig. 2B). Although the
mixture of Drep2 CIDE and the RAIDD death domain (RAIDD DD,
used as a negative control) or Drep3 CIDE and RAIDD DD did not
produce a complex band, the mixture of Drep2 CIDE and Drep3
CIDE created a new complex band. We conducted a His-tag pull-
down assay using Drep3 CIDE without the His-tag to conﬁrm the
interaction between Drep2 and Drep3. Co-expressed bacterial cell
pellets were resuspended, homogenized, and fractionated into a
soluble supernatant fraction and an insoluble fraction. The soluble
fraction, which contained both His-tagged Drep2 CIDE and Drep3
CIDE without the His-tag, was incubated with Ni-NTA beads. After
extensive washing, the beads were eluted using imidazole, and the
eluted fractions were examined by SDS–PAGE. As indicated in
Fig. 2C, Drep3 CIDE was pull-downed and co-migrated with Drep2
CIDE on SDS–PAGE, indicating that Drep2 CIDE interacts with
Drep3 CIDE.
3.3. Drep2 is novel nuclease of which activity is inhibited by Drep3
Because the biochemical behavior of Drep2 was similar with
that of DFF40 and Drep4, which possess nuclease activity, we ana-
lyzed for possible Drep2 nuclease activity using an agarose gel with
linearized plasmid DNA. Drep2 activity can be assayed by its ability
to digest plasmid DNA. While linearized plasmid DNA incubated
with water or Drep1 as a negative control was not capable of
degrading DNA, DNA incubated with Drep2 was clearly digested
(Fig. 3A). Drep3 was not able to digest DNA (Fig. 3A).
After analyzing the interaction between Drep2 CIDE and Drep3
CIDE and Drep2 nuclease activity, we wondered if the interaction
between Drep2 and Drep3 via the CIDE domain modiﬁed Drep2
activity. Thus, we conducted the same nuclease activity assay per-
formed above using a Drep2 and Drep3 mixture. As shown in the
Fig. 3B, although the Drep2 and Drep1 mixture was unable to block
Drep2 nuclease activity, Drep3 completely blocked DNA digestion,
indicating that Drep2 has nuclease activity and that the nuclease
activity of Drep2 was inhibited by Drep3 through a direct
interaction.3.4. Drep3 is cleaved by caspase-1 (Dcp1) and may be involved in
apoptotic DNA fragmentation
Interestingly, Drep3 contained the ﬂy caspase-1 (DCP-1) cleav-
age site (Fig. 4A). This observation suggests that Drep3 can be
cleaved by DCP-1 during apoptosis signaling, dissociated from
Drep2, and cause DNA fragmentation. This activity controlling sys-
tem is similar with that of the DFF40/DFF45 system found in
mammals.
Taken together, we suggest that two apoptotic DNA fragmenta-
tion systems occur in the ﬂy: theDrep1:Drep4 and Drep2:Drep3
systems. Drep4 and Drep2 are nucleases and their activity is inhib-
ited by Drep1 and Drep3, respectively. Although we were unable to
analyze the direct involvement of DCP-1 in this Drep2/Drep3
complex system due to the unavailability of active DCP-1 protein,
which is insoluble in the solution, the Drep2:Drep3 system may
O.K. Park, H.H. Park / FEBS Letters 586 (2012) 3085–3089 3089be activated by Drep3 cleavage by DCP-1. The possible chaperone
activity of Drep3 and the involvement of DCP-1 in this system
should be examined in the future.
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